Polyphenols in green tea may interfere with this cancer therapy
What is the mechanism or rationale for why a patient on bortezomib (Velcade) therapy should avoid green tea? —Connie P. Gazmen, MS, RN, OCN
Green tea interferes with the proteasome inhibitor activity of bortezomib, effectively blocking the drug’s antineoplastic effect on cancerous cells. In patient management, concurrent use of green tea extract and other green tea products should be avoided during treatment. In addition, clinicians should assess the benefits versus risk of therapy if the decision is made to initiate therapy. —Abimbola Farinde, PharmD, MS, BCPP, CGP, LCDC, PM/PRC, FASCP, FACA, FNAP, Rsci, ARSPharmS
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.